Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1254699 | Chinese Chemical Letters | 2014 | 5 Pages |
Abstract
A series of novel E-ring modified evodiamine derivatives were designed and synthesized as antitumor agents. Their capacity to interfere with the catalytic activity of topoisomerase I and II was evaluated by the relaxation assay. In vitro antitumor activity results revealed that compound 12 showed good antitumor activity with a broad spectrum. Its binding modes with topoisomerase I and II were clarified by molecular docking.
Graphical abstractA series of novel E-ring modified evodiamine derivatives were designed and synthesized as antitumor agents. Compound 12 showed good antitumor activity with a broad spectrum, which acted by dual inhibition of topoisomerase I and II.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Chemistry (General)
Authors
Kun Fang, Guo-Qiang Dong, Hai Gong, Na Liu, Zhen-Gang Li, Shi-Ping Zhu, Zhen-Yuan Miao, Jian-Zhong Yao, Wan-Nian Zhang, Chun-Quan Sheng,